GlassScriptPhysician profile
Omar Ahmad
NPI 1568623643
$14,275.59
in general payments reported to CMS, 2019-2025
66 companies · $2,558 in 2025
The $2,558 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,271 · 2020: $844 · 2021: $1,203 · 2022: $2,231 · 2023: $2,604 · 2024: $2,566 · 2025: $2,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,638 · Education: $89.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,638.39 |
| Education | $89.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,580.71 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Ucb, INC. | $1,348.37 | 2019-2025 | Nayzilam, Fintepla, Briviact |
| Novartis Pharmaceuticals Corporation | $1,262.61 | 2019-2025 | |
| Biogen, INC. | $1,046.18 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Neurocrine Biosciences, INC. | $596.70 | 2019-2025 | Ingrezza, Ongentys |
| Emd Serono, INC. | $554.21 | 2019-2025 | Mavenclad |
| Argenx US, INC. | $518.14 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Pfizer INC. | $499.91 | 2019-2025 | |
| Amgen INC. | $397.43 | 2019-2024 | Uplizna, Aimovig |
| Eisai INC. | $368.60 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $358.26 | 2019-2025 | Austedo Xr, Austedo Xr |
| Genzyme Corporation | $351.77 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $313.71 | 2019-2021 | |
| Allergan, INC. | $309.74 | 2019-2022 | |
| Sk Life Science, INC. | $309.09 | 2020-2025 |
Show all 66 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.